---
layout: post
title: "儿童肝炎病因扑朔迷离 又一国家通告5天8例 肝炎概念股六天五板"
date: 2022-05-07 08:01:20 +0800
categories: emnews
tags: 东财滚动新闻
---
> 目前已出现20个国家至少228例不明病因儿童肝炎病例。肝炎概念股六天五板，机构看好板块后市。

<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002693&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002693_0" data-code="K 002693|0|2" data-code2="K 002693|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></p><!-- EM_StockImg_End --><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/90.BK1078" data-code="BK1078|90|1" data-code2="BK1078|90|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=90.BK1078&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 BK1078_0" data-code="K BK1078|90|1" data-code2="K BK1078|90|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>目前已出现20个国家至少228例不明病因儿童肝炎病例。肝炎概念股六天五板，机构看好板块后市。<br /></p><p>根据世卫组织5月3日公布的官方数据，截至5月1日，全球范围内至少有228名儿童报告了不明原因的急性肝炎，确诊病例分布国家达到20个。在过去一周，出现病例的国家增加了8个。</p><p>据央视新闻报道，当地时间5日，阿根廷卫生部发布通告称，过去短短5天，阿根廷境内已发现8例不明原因儿童肝炎病例。通告称，8名小患者分属不同地区且相互之间不存在任何关联性。截至目前，医学界尚未找到这种新肝炎的病因。世卫组织和美国疾病预防控制中心表示，不排除是一种新病毒导致这种肝炎的发生。</p><p>A股方面，昨日肝炎概念股<strong><span id="stock_0.002693"><a href="http://quote.eastmoney.com/unify/r/0.002693" class="keytip" data-code="0,002693">双成药业</a></span><span id="quote_0.002693"></span></strong>开盘一字跌停，随后打开跌停，下午14点39分左右，股价直线爆拉并于14点44分封住涨停直至收盘，戏剧性上演“地天板”一幕。</p><center><img src="https://dfscdn.dfcfw.com/download/D24723133534754045740_w1080h1387.jpg" alt="图片" width="100%" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p>公司近6个交易日录得5个涨停板，股价创下历史新高。<span id="Info.321"><a href="http://data.eastmoney.com/stock/lhb.html" class="infokey">龙虎榜</a></span>资金昨日净买入3514.31万元。“散户大本营”之称的<span id="stock_0.300059"><a href="http://quote.eastmoney.com/unify/r/0.300059" class="keytip" data-code="0,300059">东方财富</a></span><span id="quote_0.300059"></span><span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>拉萨营业部霸榜，位列买五，卖二、卖三、卖四席位。肝炎概念股中，<strong><span id="stock_0.002644"><a href="http://quote.eastmoney.com/unify/r/0.002644" class="keytip" data-code="0,002644">佛慈制药</a></span><span id="quote_0.002644"></span>、<span id="stock_1.600056"><a href="http://quote.eastmoney.com/unify/r/1.600056" class="keytip" data-code="1,600056">中国医药</a></span><span id="quote_1.600056"></span></strong>和<strong><span id="stock_0.002864"><a href="http://quote.eastmoney.com/unify/r/0.002864" class="keytip" data-code="0,002864">盘龙药业</a></span><span id="quote_0.002864"></span></strong>昨日同样涨停。</p><center><img src="https://dfscdn.dfcfw.com/download/D25561071453303046757_w1080h2002.jpg" alt="图片" width="100%" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p><span web="1" href="http://quote.eastmoney.com/unify/r/90.BK0473" class="em_stock_key_common" data-code="90,BK0473">证券</span>时报·数据宝统计，今年以来，<strong><span web="1" href="http://quote.eastmoney.com/unify/r/1.600056" class="em_stock_key_common" data-code="1,600056">中国医药</span>、<span id="stock_1.603229"><a href="http://quote.eastmoney.com/unify/r/1.603229" class="keytip" data-code="1,603229">奥翔药业</a></span><span id="quote_1.603229"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002864" class="em_stock_key_common" data-code="0,002864">盘龙药业</span>、<span id="stock_0.300158"><a href="http://quote.eastmoney.com/unify/r/0.300158" class="keytip" data-code="0,300158">振东制药</a></span><span id="quote_0.300158"></span>、<span id="stock_0.002550"><a href="http://quote.eastmoney.com/unify/r/0.002550" class="keytip" data-code="0,002550">千红制药</a></span><span id="quote_0.002550"></span></strong>的股价累计上涨幅度均超20%，<strong><span web="1" href="http://quote.eastmoney.com/unify/r/1.600056" class="em_stock_key_common" data-code="1,600056">中国医药</span></strong>以116.77%的累计上涨幅度居首。</p><p><strong><span id="stock_0.300676"><a href="http://quote.eastmoney.com/unify/r/0.300676" class="keytip" data-code="0,300676">华大基因</a></span><span id="quote_0.300676"></span></strong>近日在官方微信公众号宣布，已紧急研制并提供腺病毒41型核酸检测及PMseq病原联合筛查方案，助力不明原因儿童急性肝炎快速筛查。</p><p><strong>4月以来，<span id="stock_0.300601"><a href="http://quote.eastmoney.com/unify/r/0.300601" class="keytip" data-code="0,300601">康泰生物</a></span><span id="quote_0.300601"></span>、<span id="stock_0.300529"><a href="http://quote.eastmoney.com/unify/r/0.300529" class="keytip" data-code="0,300529">健帆生物</a></span><span id="quote_0.300529"></span>、中国医药、振东医药、<span web="1" href="http://quote.eastmoney.com/unify/r/0.300676" class="em_stock_key_common" data-code="0,300676">华大基因</span>获得<span id="Info.3314"><a href="http://data.eastmoney.com/hsgt/index.html" class="infokey">北上资金</a></span>加仓，其中<span web="1" href="http://quote.eastmoney.com/unify/r/0.300601" class="em_stock_key_common" data-code="0,300601">康泰生物</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.300529" class="em_stock_key_common" data-code="0,300529">健帆生物</span>、中国医药的累计净买入均超亿元。</strong></p><p>25只肝炎概念股在一季度中均实现盈利，<strong><span id="stock_1.688575"><a href="http://quote.eastmoney.com/unify/r/1.688575" class="keytip" data-code="1,688575">亚辉龙</a></span><span id="quote_1.688575"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.300601" class="em_stock_key_common" data-code="0,300601">康泰生物</span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.002550" class="em_stock_key_common" data-code="0,002550">千红制药</span></strong>的一季度<span id="Info.3321"><a href="http://data.eastmoney.com/bbsj/" class="infokey">业绩</a></span>同比翻倍增长。</p><p>对于今年全年的业绩情况，机构一致预测<strong><span web="1" href="http://quote.eastmoney.com/unify/r/1.688575" class="em_stock_key_common" data-code="1,688575">亚辉龙</span>、<span id="stock_0.300009"><a href="http://quote.eastmoney.com/unify/r/0.300009" class="keytip" data-code="0,300009">安科生物</a></span><span id="quote_0.300009"></span>、<span id="stock_1.688278"><a href="http://quote.eastmoney.com/unify/r/1.688278" class="keytip" data-code="1,688278">特宝生物</a></span><span id="quote_1.688278"></span>、<span id="stock_0.300049"><a href="http://quote.eastmoney.com/unify/r/0.300049" class="keytip" data-code="0,300049">福瑞股份</a></span><span id="quote_0.300049"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/1.603229" class="em_stock_key_common" data-code="1,603229">奥翔药业</span></strong>的2022年全年<span id="Info.3324"><a href="http://data.eastmoney.com/bbsj/" class="infokey">净利润</a></span>同比大幅增长(增幅大于50%)，其中<strong><span web="1" href="http://quote.eastmoney.com/unify/r/1.688575" class="em_stock_key_common" data-code="1,688575">亚辉龙</span></strong>和<strong><span web="1" href="http://quote.eastmoney.com/unify/r/0.300009" class="em_stock_key_common" data-code="0,300009">安科生物</span></strong>有望分别增长433.1%和225.39%。</p><p>平安<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK0473" class="em_stock_key_common" data-code="90,BK0473">证券</span>认为，我国是全球肝病负担最重的国家，拥有乙肝病毒(HBV)携带者9000万人，丙肝病毒(HCV)携带者1000万人，鉴于肝病具有大量未被满足的治疗需求，创新药的市场空间值得期待。</p><center><img src="https://dfscdn.dfcfw.com/download/D25396710984702581492_w1080h790.jpg" alt="图片" width="100%" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p><strong>63股面临解禁</strong></p><p>下周将有63只股解禁，按照最新收盘价计算，合计解禁市值793.75亿元。其中<strong><span id="stock_1.603259"><a href="http://quote.eastmoney.com/unify/r/1.603259" class="keytip" data-code="1,603259">药明康德</a></span><span id="quote_1.603259"></span></strong>分别将在5月9日和12日解禁16.66万股和378.61万股。</p><p><strong><span id="stock_0.000301"><a href="http://quote.eastmoney.com/unify/r/0.000301" class="keytip" data-code="0,000301">东方盛虹</a></span><span id="quote_0.000301"></span></strong>解禁市值最大，下周将有27.68亿股上市流通，主要是定向<span id="Info.39"><a href="http://data.eastmoney.com/zrz/dxzf.html" class="infokey">增发</a></span>机构配售股份，解禁市值达339.11亿元。<strong><span id="stock_1.600906"><a href="http://quote.eastmoney.com/unify/r/1.600906" class="keytip" data-code="1,600906">财达证券</a></span><span id="quote_1.600906"></span>、<span id="stock_0.000019"><a href="http://quote.eastmoney.com/unify/r/0.000019" class="keytip" data-code="0,000019">深粮控股</a></span><span id="quote_0.000019"></span>、<span id="stock_0.300223"><a href="http://quote.eastmoney.com/unify/r/0.300223" class="keytip" data-code="0,300223">北京君正</a></span><span id="quote_0.300223"></span></strong>的解禁市值居前。</p><p><strong><span id="stock_0.000835"><a href="http://quote.eastmoney.com/unify/r/0.000835" class="keytip" data-code="0,000835">长动退</a></span><span id="quote_0.000835"></span>、<span id="stock_0.300512"><a href="http://quote.eastmoney.com/unify/r/0.300512" class="keytip" data-code="0,300512">中亚股份</a></span><span id="quote_0.300512"></span>、<span id="stock_0.300642"><a href="http://quote.eastmoney.com/unify/r/0.300642" class="keytip" data-code="0,300642">透景生命</a></span><span id="quote_0.300642"></span></strong>的解禁压力较小，解禁市值均不足千万元。</p><p>从<span id="Info.325"><a href="http://data.eastmoney.com/dxf/default.html" class="infokey">解禁股</a></span>数量占总股本的比例来看，<strong><span id="stock_1.603697"><a href="http://quote.eastmoney.com/unify/r/1.603697" class="keytip" data-code="1,603697">有友食品</a></span><span id="quote_1.603697"></span>、<span id="stock_0.002953"><a href="http://quote.eastmoney.com/unify/r/0.002953" class="keytip" data-code="0,002953">日丰股份</a></span><span id="quote_0.002953"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.000019" class="em_stock_key_common" data-code="0,000019">深粮控股</span>、<span id="stock_0.300778"><a href="http://quote.eastmoney.com/unify/r/0.300778" class="keytip" data-code="0,300778">新城市</a></span><span id="quote_0.300778"></span></strong>的解禁比例均超过50%。</p><p>数据宝统计显示，下周将要解禁的这64只股票，4月以来股价平均下跌18.35%，跑输<span id="Info.3257"><a href="http://quote.eastmoney.com/unify/r/1.000001" class="infokey">沪指</a></span>。仅有<strong><span id="stock_1.603639"><a href="http://quote.eastmoney.com/unify/r/1.603639" class="keytip" data-code="1,603639">海利尔</a></span><span id="quote_1.603639"></span>、<span id="stock_1.600901"><a href="http://quote.eastmoney.com/unify/r/1.600901" class="keytip" data-code="1,600901">江苏租赁</a></span><span id="quote_1.600901"></span>、锦好医疗、<span id="stock_1.600325"><a href="http://quote.eastmoney.com/unify/r/1.600325" class="keytip" data-code="1,600325">华发股份</a></span><span id="quote_1.600325"></span>、<span id="stock_1.601611"><a href="http://quote.eastmoney.com/unify/r/1.601611" class="keytip" data-code="1,601611">中国核建</a></span><span id="quote_1.601611"></span></strong>的涨跌幅累计录得正值。<strong><span id="stock_0.300988"><a href="http://quote.eastmoney.com/unify/r/0.300988" class="keytip" data-code="0,300988">津荣天宇</a></span><span id="quote_0.300988"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/1.600906" class="em_stock_key_common" data-code="1,600906">财达证券</span>、<span id="stock_1.688355"><a href="http://quote.eastmoney.com/unify/r/1.688355" class="keytip" data-code="1,688355">明志科技</a></span><span id="quote_1.688355"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/0.000835" class="em_stock_key_common" data-code="0,000835">长动退</span></strong>等8股的股价跌幅居前，均下跌超30%。</p><p>根据一季报业绩来看，<strong><span id="stock_1.600809"><a href="http://quote.eastmoney.com/unify/r/1.600809" class="keytip" data-code="1,600809">山西汾酒</a></span><span id="quote_1.600809"></span></strong>的盈利最高，一季度实现<span id="Info.3323"><a href="http://data.eastmoney.com/bbsj/" class="infokey">营业收入</a></span>105.3亿元，同比增长43.62%；净利润37.1亿元，同比增长70.03%。报告期内，<strong><span web="1" href="http://quote.eastmoney.com/unify/r/1.600809" class="em_stock_key_common" data-code="1,600809">山西汾酒</span></strong>在南方市场销售平均增幅达60%以上。<strong><span id="stock_0.300769"><a href="http://quote.eastmoney.com/unify/r/0.300769" class="keytip" data-code="0,300769">德方纳米</a></span><span id="quote_0.300769"></span>、<span id="stock_0.002821"><a href="http://quote.eastmoney.com/unify/r/0.002821" class="keytip" data-code="0,002821">凯莱英</a></span><span id="quote_0.002821"></span>、<span id="stock_1.688107"><a href="http://quote.eastmoney.com/unify/r/1.688107" class="keytip" data-code="1,688107">安路科技-U</a></span><span id="quote_1.688107"></span>、<span id="stock_0.300568"><a href="http://quote.eastmoney.com/unify/r/0.300568" class="keytip" data-code="0,300568">星源材质</a></span><span id="quote_0.300568"></span></strong>的2022年第一季度业绩同比翻倍上涨。相比之下，<strong><span id="stock_1.688655"><a href="http://quote.eastmoney.com/unify/r/1.688655" class="keytip" data-code="1,688655">迅捷兴</a></span><span id="quote_1.688655"></span>、<span id="stock_0.002361"><a href="http://quote.eastmoney.com/unify/r/0.002361" class="keytip" data-code="0,002361">神剑股份</a></span><span id="quote_0.002361"></span>、<span id="stock_0.002835"><a href="http://quote.eastmoney.com/unify/r/0.002835" class="keytip" data-code="0,002835">同为股份</a></span><span id="quote_0.002835"></span>、<span id="stock_1.600841"><a href="http://quote.eastmoney.com/unify/r/1.600841" class="keytip" data-code="1,600841">动力新科</a></span><span id="quote_1.600841"></span>、<span id="stock_1.603385"><a href="http://quote.eastmoney.com/unify/r/1.603385" class="keytip" data-code="1,603385">惠达卫浴</a></span><span id="quote_1.603385"></span></strong>的业绩同比下降幅度均超70%。</p><center><img src="https://dfscdn.dfcfw.com/download/D24887115782165452172_w1080h2724.jpg" alt="图片" width="100%" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p class="em_media">（文章来源：数据宝）</p>

<http://finance.eastmoney.com/news/1344,202205072371136479.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)